CHEST 2023 On Demand Pass-Best of CHEST Journal: Chest Infections

Video Transcription

Video Summary

The video transcript discusses two topics in the field of chest infections. The first topic is pneumonia in high-risk populations, specifically focusing on pneumonia in patients with chronic obstructive pulmonary disease (COPD) and immunocompromised patients. The speaker presents research findings on the microbiological patterns associated with risk factors that determine antimicrobial therapy in hospitalized COPD patients. The study found that the majority of COPD patients with pneumonia had no identifiable pathogen, but when pathogens were identified, gram-negative bacteria, pneumococcus, Pseudomonas aeruginosa, and Haemophilus influenzae were the most common. The speaker also introduces a scoring system based on risk factors that can help guide empirical antibiotic therapy for pseudomonas aeruginosa in COPD patients. For immunocompromised patients with pneumonia, the speaker highlights the need to redefine the approach to diagnosis and management. The second topic discussed in the video is patient-reported outcomes (PROs) in the treatment of Mycobacterium avium complex (MAC) pulmonary disease. The speaker emphasizes the importance of PROs in the drug approval process and discusses a study that evaluated the QOLB instrument for quality of life assessment in MAC patients. The study found that the QOLB instrument was a valid and responsive measurement tool for assessing respiratory symptoms in MAC patients. The video concludes with the mention of ongoing research and clinical trials in the field of chest infections.

Meta Tag

Category Chest Infections

Session ID 2251

Speaker Vicente Corrales-Medina

Speaker Vidya Mave

Speaker Ignacio Melero

Track Chest Infections

Keywords

chest infections

pneumonia

COPD

immunocompromised patients

antimicrobial therapy

pseudomonas aeruginosa

patient-reported outcomes

MAC pulmonary disease

Chronic Obstructive Pulmonary Disease